DFX Intelligence

Allocator Intelligence

The capital-owner graph behind private markets. Who owns the capital, who decides, how much, under what policy, on whose advice, to which managers, and what changed, with a source and a date behind every row. A target is never an actual, a disclosed holding is never an approval, and an estimate says so.

Corporate pension

Oncology/hematology Care, Inc. Defined Benefit Plan

Corporate pensionCincinnati, OH
Assets
$5.4M
Total assets, Dec 31, 2024 reported
Funded
120.9%
Jan 1, 2024
Private markets target
n/a
policy Dec 31, 2024
Commitments
0
none on the tape
Plan sponsor: Oncology/hematology Care, Inc.
Allocation policy
Form 5500, as of Dec 31, 2024
Actual allocation lines without a target (as filed)
  • Interest-bearing cash 7.4%
  • Other investments 33.7%
  • Registered investment companies 59.0%
Consultants and advisers
1 firms
People
No investment staff or executives have been read for this allocator yet.
Manager roster
1 managers on Schedule C
From Schedule C (investment management, code 28)
Commitments
No fund commitments are on the tape for this allocator. The tape holds the plans that publish their own private-markets reports; a plan that publishes one and is not here is a gap we can close.
Size and funding
33 readings
Total assets
$5.4M Dec 31, 2024 reported Form 5500
$4.5M (2023-12) · $6.8M (2022-12)
Plan assets
$4.5M Jan 1, 2024 reported Form 5500
$6.8M (2023-01) · $8.3M (2022-01)
Net assets
$5.4M Dec 31, 2024 reported Form 5500
$4.5M (2023-12) · $6.8M (2022-12)
Funded ratio
120.9% Jan 1, 2024 reported Form 5500
108.9% (2023-01) · 143.3% (2022-01)
Funding target
$3.7M Jan 1, 2024 reported Form 5500
$6.3M (2023-01) · $5.8M (2022-01)
Discount rate
5.27% Jan 1, 2024 reported Form 5500
5.31% (2023-01) · 5.37% (2022-01)
Participants
149 Jan 1, 2024 reported Form 5500
161 (2023-01) · 164 (2022-01)
Contributions
$1.2M Dec 31, 2024 reported Form 5500
$1.1M (2023-12) · $1.8M (2022-12)
Benefits paid
$774,848 Dec 31, 2024 reported Form 5500
$4.0M (2023-12) · $2.1M (2022-12)
Net investment income
$890,176 Dec 31, 2024 reported Form 5500
$-2.3M (2023-12) · $-1.5M (2022-12)
Investment management fees
$17,034 Dec 31, 2024 reported Form 5500
$17,143 (2023-12) · $0 (2022-12)
Form 5500 filings
3 plan years
Plan yearParticipantsAssets (SB market)Funding targetFTAPTotal assets (H)Partnerships / JVMaster trustReal estate
2024 to Dec 31, 2024149$4.5M$3.7M120.9%$5.4Mn/an/an/a
2023 to Dec 31, 2023161$6.8M$6.3M108.9%$4.5Mn/an/an/a
2022 to Dec 31, 2022164$8.3M$5.8M143.3%$6.8Mn/an/an/a
Service providers and investment entities as filed (Schedule C and D, latest year first)
What changed
6 events
  • Dec 31, 2024Assets changed
    Oncology/hematology Care, Inc. Defined Benefit Plan total assets $5M -> $5M (+19.7%, 2023-12-31 to 2024-12-31)
  • Jan 1, 2024Funded status changed
    Oncology/hematology Care, Inc. Defined Benefit Plan funded ratio 108.9% -> 120.9% (2023-01-01 to 2024-01-01)
  • Jan 1, 2024Assets changed
    Oncology/hematology Care, Inc. Defined Benefit Plan plan assets $7M -> $5M (-33.5%, 2023-01-01 to 2024-01-01)
  • Dec 31, 2023Assets changed
    Oncology/hematology Care, Inc. Defined Benefit Plan total assets $7M -> $5M (-33.5%, 2022-12-31 to 2023-12-31)
  • Jan 1, 2023Funded status changed
    Oncology/hematology Care, Inc. Defined Benefit Plan funded ratio 143.3% -> 108.9% (2022-01-01 to 2023-01-01)
  • Jan 1, 2023Assets changed
    Oncology/hematology Care, Inc. Defined Benefit Plan plan assets $8M -> $7M (-18.1%, 2022-01-01 to 2023-01-01)
Board record: approvals, recommendations, searches, terminations and re-up prospects for this system.
Provenance
Identifiers: EIN-PN 311106418-004
Cross-graph: no entry on another DFX graph
First observed Sep 15, 2026, last observed Sep 15, 2026. Classification confirmed. Every row above carries its source; a reported figure is the subject’s own, a derived one is arithmetic on reported figures, an estimated one is a model or a survey imputation and is never summed into a headline.